Jerusalem, Israel

Muneef Ayyash

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muneef Ayyash: Innovator in Drug Screening Technologies

Introduction

Muneef Ayyash is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of drug development through his innovative research and patents. His work focuses on enhancing the efficiency of drug screening processes.

Latest Patents

Muneef Ayyash holds a patent titled "Methods of Generating Organoids for High Throughput Screening of Drugs." This patent represents a breakthrough in the ability to create organoids that can be used for more effective drug testing, potentially leading to faster and more reliable results in pharmaceutical research.

Career Highlights

Throughout his career, Ayyash has been associated with prominent research institutions. He has worked with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Yeda Research and Development Co. Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Muneef Ayyash has collaborated with esteemed colleagues, including Avner Ehrlich and Yaakov Nahmias. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.

Conclusion

Muneef Ayyash is a pioneering inventor whose work in drug screening technologies is paving the way for advancements in pharmaceutical research. His contributions are expected to have a lasting impact on the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…